These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gene therapy in the CNS. Costantini LC; Bakowska JC; Breakefield XO; Isacson O Gene Ther; 2000 Jan; 7(2):93-109. PubMed ID: 10673714 [TBL] [Abstract][Full Text] [Related]
6. Targeting the heart with gene therapy-optimized gene delivery methods. Müller OJ; Katus HA; Bekeredjian R Cardiovasc Res; 2007 Feb; 73(3):453-62. PubMed ID: 17097076 [TBL] [Abstract][Full Text] [Related]
7. Viral vector systems for gene therapy. Jolly D Cancer Gene Ther; 1994 Mar; 1(1):51-64. PubMed ID: 7621239 [No Abstract] [Full Text] [Related]
8. Viral gene therapy strategies: from basic science to clinical application. Young LS; Searle PF; Onion D; Mautner V J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990 [TBL] [Abstract][Full Text] [Related]
9. Infection control for gene therapy: a busy physician's primer. Evans ME; Lesnaw JA Clin Infect Dis; 2002 Sep; 35(5):597-605. PubMed ID: 12173136 [TBL] [Abstract][Full Text] [Related]
10. Progress and problems with the use of viral vectors for gene therapy. Thomas CE; Ehrhardt A; Kay MA Nat Rev Genet; 2003 May; 4(5):346-58. PubMed ID: 12728277 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy progress and prospects: adenoviral vectors. St George JA Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Sinn PL; Sauter SL; McCray PB Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340 [TBL] [Abstract][Full Text] [Related]
14. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Romano G; Michell P; Pacilio C; Giordano A Stem Cells; 2000; 18(1):19-39. PubMed ID: 10661569 [TBL] [Abstract][Full Text] [Related]
15. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. Rolling F Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954 [TBL] [Abstract][Full Text] [Related]
16. AAV vector re-targeting: A small step on the way to cardiac-specific gene transfer. Gödecke A Cardiovasc Res; 2006 Apr; 70(1):6-8. PubMed ID: 16524565 [No Abstract] [Full Text] [Related]
17. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors. Le Bec C; Douar AM Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010 [TBL] [Abstract][Full Text] [Related]
19. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187 [TBL] [Abstract][Full Text] [Related]